{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:21:48Z","timestamp":1792030908924,"version":"4.4.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Several metabolomics studies have shed substantial light on the pathophysiological pathways underlying multiple diseases including systemic lupus erythematosus (SLE). This review takes stock of our current understanding of this field. We compare, collate, and investigate the metabolites in SLE patients and healthy volunteers, as gleaned from published metabolomics studies on SLE. In the surveyed primary reports, serum or plasma samples from SLE patients and healthy controls were assayed using mass spectrometry or nuclear magnetic resonance spectroscopy, and metabolites differentiating SLE from controls were identified. Collectively, the circulating metabolome in SLE is characterized by reduced energy substrates from glycolysis, Krebs cycle, fatty acid \u03b2 oxidation, and glucogenic and ketogenic amino acid metabolism; enhanced activity of the urea cycle; decreased long-chain fatty acids; increased medium-chain and free fatty acids; and augmented peroxidation and inflammation. However, these findings should be interpreted with caution because several of the same metabolic pathways are also significantly influenced by the medications commonly used in SLE patients, common co-morbidities, and other factors including smoking and diet. In particular, whereas the metabolic alterations relating to inflammation, oxidative stress, lipid peroxidation, and glutathione generation do not appear to be steroid-dependent, the other metabolic changes may in part be influenced by steroids. To conclude, metabolomics studies of SLE and other rheumatic diseases ought to factor in the potential contributions of confounders such as medications, co-morbidities, smoking, and diet.<\/jats:p>","DOI":"10.1186\/s13075-020-02264-2","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T14:26:01Z","timestamp":1594995961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Caution in studying and interpreting the lupus metabolome"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8616-9733","authenticated-orcid":false,"given":"Ting","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,17]]},"reference":[{"key":"2264_CR1","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365:2110\u201321.","journal-title":"N Engl J Med"},{"key":"2264_CR2","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1172\/JCI83005","volume":"126","author":"N Assmann","year":"2016","unstructured":"Assmann N, Finlay DK. Metabolic regulation of immune responses: therapeutic opportunities. J Clin Invest. 2016;126:2031\u20139.","journal-title":"J Clin Invest"},{"key":"2264_CR3","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","volume":"16","author":"LA O'Neill","year":"2016","unstructured":"O'Neill LA, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016;16:553\u201365.","journal-title":"Nat Rev Immunol"},{"key":"2264_CR4","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nrrheum.2017.43","volume":"13","author":"L Morel","year":"2017","unstructured":"Morel L. Immunometabolism in systemic lupus erythematosus. Nat Rev Rheumatol. 2017;13:280\u201390.","journal-title":"Nat Rev Rheumatol"},{"key":"2264_CR5","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1177\/0961203311418707","volume":"20","author":"X Ouyang","year":"2011","unstructured":"Ouyang X, Dai Y, Wen JL, Wang LX. (1) H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus. Lupus. 2011;20:1411\u201320.","journal-title":"Lupus"},{"key":"2264_CR6","doi-asserted-by":"crossref","first-page":"e37210","DOI":"10.1371\/journal.pone.0037210","volume":"7","author":"T Wu","year":"2012","unstructured":"Wu T, Xie C, Han J, Ye Y, Weiel J, Li Q, et al. Metabolic disturbances associated with systemic lupus erythematosus. PLoS One. 2012;7:e37210.","journal-title":"PLoS One"},{"key":"2264_CR7","doi-asserted-by":"crossref","first-page":"e0159384","DOI":"10.1371\/journal.pone.0159384","volume":"11","author":"AA Bengtsson","year":"2016","unstructured":"Bengtsson AA, Trygg J, Wuttge DM, Sturfelt G, Theander E, Donten M, et al. Metabolic profiling of systemic lupus erythematosus and comparison with primary Sjogren\u2019s syndrome and systemic sclerosis. PLoS One. 2016;11:e0159384.","journal-title":"PLoS One"},{"key":"2264_CR8","doi-asserted-by":"crossref","first-page":"35309","DOI":"10.1038\/srep35309","volume":"6","author":"A Guleria","year":"2016","unstructured":"Guleria A, Pratap A, Dubey D, Rawat A, Chaurasia S, Sukesh E, et al. NMR based serum metabolomics reveals a distinctive signature in patients with lupus nephritis. Sci Rep. 2016;6:35309.","journal-title":"Sci Rep"},{"key":"2264_CR9","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3109\/14397595.2016.1158895","volume":"26","author":"B Yan","year":"2016","unstructured":"Yan B, Huang J, Zhang C, Hu X, Gao M, Shi A, et al. Serum metabolomic profiling in patients with systemic lupus erythematosus by GC\/MS. Mod Rheumatol. 2016;26:914\u201322.","journal-title":"Mod Rheumatol"},{"key":"2264_CR10","doi-asserted-by":"crossref","unstructured":"Shin TH, Kim H-A, Jung J-Y, Baek W-Y, Lee H-S, Park HJ, et al. Analysis of the free fatty acid metabolome in the plasma of patients with systemic lupus erythematosus and fever. Metabolomics. 2017;14.","DOI":"10.1007\/s11306-017-1308-6"},{"key":"2264_CR11","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1021\/acs.jproteome.8b00192","volume":"17","author":"A Guleria","year":"2018","unstructured":"Guleria A, Phatak S, Dubey D, Kumar S, Zanwar A, Chaurasia S, et al. NMR-based serum metabolomics reveals reprogramming of lipid dysregulation following cyclophosphamide-based induction therapy in lupus nephritis. J Proteome Res. 2018;17:2440\u20138.","journal-title":"J Proteome Res"},{"key":"2264_CR12","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1177\/0961203317694256","volume":"26","author":"JXX Li","year":"2017","unstructured":"Li JXX, Zhou H, Wang B, Zhang MJ, Tang FY. Metabolic profiling reveals new serum biomarkers of lupus nephritis. Lupus. 2017;26:1166\u201373.","journal-title":"Lupus"},{"key":"2264_CR13","doi-asserted-by":"crossref","unstructured":"Bellocchi C, Fernandez-Ochoa A, Montanelli G, Vigone B, Santaniello A, Quirantes-Pine R, et al. Identification of a shared microbiomic and metabolomic profile in systemic autoimmune diseases. J Clin Med. 2019;8.","DOI":"10.3390\/jcm8091291"},{"key":"2264_CR14","first-page":"857","volume":"12","author":"YLL Li","year":"2019","unstructured":"Li YLL, Deng X, Zhong L. Lipidomic and metabolomic profiling reveals novel candidate biomarkers in active systemic lupus erythematosus. Int J Clin Exp Pathol. 2019;12:857\u201366.","journal-title":"Int J Clin Exp Pathol"},{"key":"2264_CR15","doi-asserted-by":"crossref","unstructured":"Zhang Q, Li X, Yin X, Wang H, Fu C, Wang H, et al. Metabolomic profiling reveals serum L-pyroglutamic acid as a potential diagnostic biomarker for systemic lupus erythematosus. Rheumatology (Oxford) 2020.","DOI":"10.1093\/rheumatology\/keaa126"},{"key":"2264_CR16","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1177\/0961203317751860","volume":"27","author":"HALH Kim","year":"2018","unstructured":"Kim HALH, Shin TH, Jung JY, Baek WY, Park HJ, Lee G, Paik MJ, Suh CH. Polyamine patterns in plasma of patients with systemic lupus erythematosus and fever. Lupus. 2018;27:930\u20138.","journal-title":"Lupus"},{"key":"2264_CR17","doi-asserted-by":"crossref","first-page":"15169","DOI":"10.1038\/s41598-019-51285-8","volume":"9","author":"SM Lee","year":"2019","unstructured":"Lee SM, Lee EM, Park JK, Jeon HS, Oh S, Hong S, et al. Metabolic biomarkers in midtrimester maternal plasma can accurately predict adverse pregnancy outcome in patients with SLE. Sci Rep. 2019;9:15169.","journal-title":"Sci Rep"},{"key":"2264_CR18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fphar.2018.00046","volume":"9","author":"AK Malkawi","year":"2018","unstructured":"Malkawi AK, Alzoubi KH, Jacob M, Matic G, Ali A, Al Faraj A, et al. Metabolomics based profiling of dexamethasone side effects in rats. Front Pharmacol. 2018;9:46.","journal-title":"Front Pharmacol"},{"key":"2264_CR19","doi-asserted-by":"crossref","first-page":"15954","DOI":"10.1038\/srep15954","volume":"5","author":"N Bordag","year":"2015","unstructured":"Bordag N, Klie S, Jurchott K, Vierheller J, Schiewe H, Albrecht V, et al. Glucocorticoid (dexamethasone)-induced metabolome changes in healthy males suggest prediction of response and side effects. Sci Rep. 2015;5:15954.","journal-title":"Sci Rep"},{"key":"2264_CR20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1530\/EJE-17-0109","volume":"177","author":"G Di Dalmazi","year":"2017","unstructured":"Di Dalmazi G, Quinkler M, Deutschbein T, Prehn C, Rayes N, Kroiss M, et al. Cortisol-related metabolic alterations assessed by mass spectrometry assay in patients with Cushing\u2019s syndrome. Eur J Endocrinol. 2017;177:227\u201337.","journal-title":"Eur J Endocrinol"},{"key":"2264_CR21","unstructured":"Gropper S SJ, Groff J. Carbohydrates. In: P A, editor. Advanced nutrition and human metabolism. Belmont: Cengage; 2009. p. 63\u2013105."},{"key":"2264_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00726-009-0269-0","volume":"37","author":"G Wu","year":"2009","unstructured":"Wu G. Amino acids: metabolism, functions, and nutrition. Amino Acids. 2009;37:1\u201317.","journal-title":"Amino Acids"},{"key":"2264_CR23","first-page":"695","volume-title":"Lehninger principles of biochemistry","author":"NDL CM","year":"2013","unstructured":"CM NDL. Amino acid oxidation and the production of urea. In: LS, editor. Lehninger principles of biochemistry. New York: W.H. Freeman; 2013. p. 695\u2013730."},{"key":"2264_CR24","first-page":"357","volume-title":"Lehninger principles of biochemistry","author":"NDL CM","year":"2013","unstructured":"CM NDL. Lipids. In: LS, editor. Lehninger principles of biochemistry. New York: W.H. Freeman; 2013. p. 357\u201384."},{"key":"2264_CR25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12026-017-8960-9","volume":"66","author":"BM Scavuzzi","year":"2018","unstructured":"Scavuzzi BM, Simao ANC, Iriyoda TMV, Lozovoy MAB, Stadtlober NP, Franchi Santos L, et al. Increased lipid and protein oxidation and lowered anti-oxidant defenses in systemic lupus erythematosus are associated with severity of illness, autoimmunity, increased adhesion molecules, and Th1 and Th17 immune shift. Immunol Res. 2018;66:158\u201371.","journal-title":"Immunol Res"},{"key":"2264_CR26","doi-asserted-by":"crossref","unstructured":"Lu L, Hu C, Zhao Y, He L, Zhou J, Li H, et al. Shotgun lipidomics revealed altered profiles of serum lipids in systemic lupus erythematosus closely associated with disease activity. Biomolecules. 2018;8.","DOI":"10.3390\/biom8040105"},{"key":"2264_CR27","doi-asserted-by":"crossref","unstructured":"Shah D, Mahajan N, Sah S, Nath SK, Paudyal B. Oxidative stress and its biomarkers in systemic lupus erythematosus. J Biomed Sci. 2014;21.","DOI":"10.1186\/1423-0127-21-23"},{"key":"2264_CR28","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.20780","volume":"52","author":"J Frostegard","year":"2005","unstructured":"Frostegard J, Svenungsson E, Wu RH, Gunnarsson I, Lundberg IE, Klareskog L, et al. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Arthritis Rheum-Us. 2005;52:192\u2013200.","journal-title":"Arthritis Rheum-Us"},{"key":"2264_CR29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/2042018814547204","volume":"5","author":"MP Hage","year":"2014","unstructured":"Hage MP, Al-Badri MR, Azar ST. A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role. Ther Adv Endocrinol Metab. 2014;5:77\u201385.","journal-title":"Ther Adv Endocrinol Metab"},{"key":"2264_CR30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/1756-185X.13159","volume":"21","author":"H Babary","year":"2018","unstructured":"Babary H, Liu X, Ayatollahi Y, Chen XP, Doo L, Uppaluru LK, et al. Favorable effects of hydroxychloroquine on serum low density lipid in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Int J Rheum Dis. 2018;21:84\u201392.","journal-title":"Int J Rheum Dis"},{"key":"2264_CR31","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3899\/jrheum.150437","volume":"43","author":"L Durcan","year":"2016","unstructured":"Durcan L, Winegar DA, Connelly MA, Otvos JD, Magder LS, Petri M. Longitudinal evaluation of lipoprotein variables in systemic lupus erythematosus reveals adverse changes with disease activity and prednisone and more favorable profiles with hydroxychloroquine therapy. J Rheumatol. 2016;43:745\u201350.","journal-title":"J Rheumatol"},{"key":"2264_CR32","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.mce.2012.10.030","volume":"365","author":"MJ Pereira","year":"2013","unstructured":"Pereira MJ, Palming J, Rizell M, Aureliano M, Carvalho E, Svensson MK, et al. The immunosuppressive agents rapamycin, cyclosporin A and tacrolimus increase lipolysis, inhibit lipid storage and alter expression of genes involved in lipid metabolism in human adipose tissue. Mol Cell Endocrinol. 2013;365:260\u20139.","journal-title":"Mol Cell Endocrinol"},{"key":"2264_CR33","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ecl.2007.07.003","volume":"36","author":"S Subramanian","year":"2007","unstructured":"Subramanian S, Trence DL. Immunosuppressive agents: effects on glucose and lipid metabolism. Endocrinol Metab Clin N Am. 2007;36:891\u2013905 vii.","journal-title":"Endocrinol Metab Clin N Am"},{"key":"2264_CR34","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/ndt\/gfw291","volume":"31","author":"MF Nieto","year":"2016","unstructured":"Nieto MF, Jayne DR. Con: the use of calcineurin inhibitors in the treatment of lupus nephritis. Nephrol Dial Transpl. 2016;31:1567\u201371.","journal-title":"Nephrol Dial Transpl"},{"key":"2264_CR35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1741-7015-11-60","volume":"11","author":"T Xu","year":"2013","unstructured":"Xu T, Holzapfel C, Dong X, Bader E, Yu Z, Prehn C, et al. Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort study. BMC Med. 2013;11:60.","journal-title":"BMC Med"},{"key":"2264_CR36","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/all.12376","volume":"69","author":"NC Thomson","year":"2014","unstructured":"Thomson NC, Chaudhuri R, Spears M, Messow CM, Jelinsky S, Miele G, et al. Arachidonic acid metabolites and enzyme transcripts in asthma are altered by cigarette smoking. Allergy. 2014;69:527\u201336.","journal-title":"Allergy"},{"key":"2264_CR37","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2337\/db12-0495","volume":"62","author":"A Floegel","year":"2013","unstructured":"Floegel A, Stefan N, Yu Z, Muhlenbruch K, Drogan D, Joost HG, et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes. 2013;62:639\u201348.","journal-title":"Diabetes"},{"key":"2264_CR38","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1210\/jc.2017-02139","volume":"103","author":"E Strand","year":"2018","unstructured":"Strand E, Rebnord EW, Flygel MR, Lysne V, Svingen GFT, Tell GS, et al. Serum carnitine metabolites and incident type 2 diabetes mellitus in patients with suspected stable angina pectoris. J Clin Endocrinol Metab. 2018;103:1033\u201341.","journal-title":"J Clin Endocrinol Metab"},{"key":"2264_CR39","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1373\/clinchem.2014.228965","volume":"61","author":"D Drogan","year":"2015","unstructured":"Drogan D, Dunn WB, Lin W, Buijsse B, Schulze MB, Langenberg C, et al. Untargeted metabolic profiling identifies altered serum metabolites of type 2 diabetes mellitus in a prospective, nested case control study. Clin Chem. 2015;61:487\u201397.","journal-title":"Clin Chem"},{"key":"2264_CR40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1021\/pr500825y","volume":"14","author":"T Wu","year":"2015","unstructured":"Wu T, Xie G, Ni Y, Liu T, Yang M, Wei H, et al. Serum metabolite signatures of type 2 diabetes mellitus complications. J Proteome Res. 2015;14:447\u201356.","journal-title":"J Proteome Res"},{"key":"2264_CR41","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.jacc.2015.02.019","volume":"65","author":"TJ Wang","year":"2015","unstructured":"Wang TJ, Gupta DK. Metabolite profiles in heart failure: looking for unique signatures in a heterogeneous syndrome. J Am Coll Cardiol. 2015;65:1521\u20134.","journal-title":"J Am Coll Cardiol"},{"key":"2264_CR42","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/HYPERTENSIONAHA.116.07292","volume":"68","author":"S Dietrich","year":"2016","unstructured":"Dietrich S, Floegel A, Weikert C, Prehn C, Adamski J, Pischon T, et al. Identification of serum metabolites associated with incident hypertension in the European Prospective Investigation into Cancer and Nutrition-Potsdam Study. Hypertension. 2016;68:471\u20137.","journal-title":"Hypertension"},{"key":"2264_CR43","first-page":"855","volume":"77","author":"AM Eudy","year":"2018","unstructured":"Eudy AM, Siega-Riz AM, Engel SM, Franceschini N, Howard AG, Clowse MEB, et al. Effect of pregnancy on disease flares in patients with systemic lupus erythematosus. Ann Rheum Dis. 2018;77:855\u201360.","journal-title":"Ann Rheum Dis"},{"key":"2264_CR44","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.imbio.2017.11.004","volume":"223","author":"R Yacoub","year":"2018","unstructured":"Yacoub R, Jacob A, Wlaschin J, McGregor M, Quigg RJ, Alexander JJ. Lupus: the microbiome angle. Immunobiology. 2018;223:460\u20135.","journal-title":"Immunobiology"},{"key":"2264_CR45","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aar7201","volume":"359","author":"S Manfredo Vieira","year":"2018","unstructured":"Manfredo Vieira S, Hiltensperger M, Kumar V, Zegarra-Ruiz D, Dehner C, Khan N, et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science. 2018;359:1156\u201361.","journal-title":"Science"},{"key":"2264_CR46","first-page":"608","volume":"6","author":"Q Mu","year":"2015","unstructured":"Mu Q, Zhang H, Luo XM. SLE: another autoimmune disorder influenced by microbes and diet? Front Immunol. 2015;6:608.","journal-title":"Front Immunol"},{"key":"2264_CR47","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1042\/CS20180841","volume":"133","author":"Y Li","year":"2019","unstructured":"Li Y, Wang HF, Li X, Li HX, Zhang Q, Zhou HW, et al. Disordered intestinal microbes are associated with the activity of Systemic Lupus Erythematosus. Clin Sci (Lond). 2019;133:821\u201338.","journal-title":"Clin Sci (Lond)"},{"key":"2264_CR48","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1136\/annrheumdis-2018-214856","volume":"78","author":"D Azzouz","year":"2019","unstructured":"Azzouz D, Omarbekova A, Heguy A, Schwudke D, Gisch N, Rovin BH, et al. Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. Ann Rheum Dis. 2019;78:947\u201356.","journal-title":"Ann Rheum Dis"},{"key":"2264_CR49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s40168-017-0300-8","volume":"5","author":"Q Mu","year":"2017","unstructured":"Mu Q, Zhang H, Liao X, Lin K, Liu H, Edwards MR, et al. Control of lupus nephritis by changes of gut microbiota. Microbiome. 2017;5:73.","journal-title":"Microbiome"},{"key":"2264_CR50","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/jn\/nxz328","volume":"150","author":"R Gudi","year":"2020","unstructured":"Gudi R, Suber J, Brown R, Johnson BM, Vasu C. Pretreatment with yeast-derived complex dietary polysaccharides suppresses gut inflammation, alters the microbiota composition, and increases immune regulatory short-chain fatty acid production in C57BL\/6 mice. J Nutr. 2020;150:1291\u2013302.","journal-title":"J Nutr"},{"key":"2264_CR51","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ni.2640","volume":"14","author":"JR Brestoff","year":"2013","unstructured":"Brestoff JR, Artis D. Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol. 2013;14:676\u201384.","journal-title":"Nat Immunol"},{"key":"2264_CR52","doi-asserted-by":"crossref","unstructured":"Rodriguez-Carrio J, Lopez P, Sanchez B, Gonzalez S, Gueimonde M, Margolles A, et al. Intestinal dysbiosis is associated with altered short-chain fatty acids and serum-free fatty acids in systemic lupus erythematosus. Front Immunol. 2017;8.","DOI":"10.3389\/fimmu.2017.00023"},{"key":"2264_CR53","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature24661","volume":"551","author":"D Dodd","year":"2017","unstructured":"Dodd D, Spitzer MH, Van Treuren W, Merrill BD, Hryckowian AJ, Higginbottom SK, et al. A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature. 2017;551:648.","journal-title":"Nature"},{"key":"2264_CR54","doi-asserted-by":"crossref","unstructured":"Wang J, Wang Y, Zhang X, Liu JQ, Zhang QP, Zhao Y, et al. Gut microbial dysbiosis is associated with altered hepatic functions and serum metabolites in chronic hepatitis B patients. Front Microbiol. 2017;8.","DOI":"10.3389\/fmicb.2017.02222"},{"key":"2264_CR55","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nm.4358","volume":"23","author":"RX Liu","year":"2017","unstructured":"Liu RX, Hong J, Xu XQ, Feng Q, Zhang DY, Gu YY, et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat Med. 2017;23:859.","journal-title":"Nat Med"},{"key":"2264_CR56","doi-asserted-by":"crossref","unstructured":"Org E, Blum Y, Kasela S, Mehrabian M, Kuusisto J, Kangas AJ, et al. Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort. Genome Biol. 2017;18.","DOI":"10.1186\/s13059-017-1194-2"},{"key":"2264_CR57","doi-asserted-by":"crossref","first-page":"13523","DOI":"10.1038\/s41598-017-14010-x","volume":"7","author":"PM Ryan","year":"2017","unstructured":"Ryan PM, Patterson E, Kent RM, Stack H, O'Connor PM, Murphy K, et al. Recombinant incretin-secreting microbe improves metabolic dysfunction in high-fat diet fed rodents. Sci Rep. 2017;7:13523.","journal-title":"Sci Rep"},{"key":"2264_CR58","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1017\/S0029665114000688","volume":"74","author":"J Maukonen","year":"2015","unstructured":"Maukonen J, Saarela M. Human gut microbiota: does diet matter? Proc Nutr Soc. 2015;74:23\u201336.","journal-title":"Proc Nutr Soc"},{"key":"2264_CR59","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2796.2010.02270.x","volume":"268","author":"R Caesar","year":"2010","unstructured":"Caesar R, Fak F, Backhed F. Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism. J Intern Med. 2010;268:320\u20138.","journal-title":"J Intern Med"},{"key":"2264_CR60","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ejcn.2013.147","volume":"67","author":"A Floegel","year":"2013","unstructured":"Floegel A, von Ruesten A, Drogan D, Schulze MB, Prehn C, Adamski J, et al. Variation of serum metabolites related to habitual diet: a targeted metabolomic approach in EPIC-Potsdam. Eur J Clin Nutr. 2013;67:1100\u20138.","journal-title":"Eur J Clin Nutr"},{"key":"2264_CR61","doi-asserted-by":"crossref","first-page":"8620","DOI":"10.1038\/s41598-018-26441-1","volume":"8","author":"T Akbaraly","year":"2018","unstructured":"Akbaraly T, Wurtz P, Singh-Manoux A, Shipley MJ, Haapakoski R, Lehto M, et al. Association of circulating metabolites with healthy diet and risk of cardiovascular disease: analysis of two cohort studies. Sci Rep. 2018;8:8620.","journal-title":"Sci Rep"},{"key":"2264_CR62","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/ajcn\/nqy202","volume":"109","author":"CM Rebholz","year":"2019","unstructured":"Rebholz CM, Zheng Z, Grams ME, Appel LJ, Sarnak MJ, Inker LA, et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. Am J Clin Nutr. 2019;109:517\u201325.","journal-title":"Am J Clin Nutr"},{"key":"2264_CR63","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s11306-015-0772-0","volume":"11","author":"A Perl","year":"2015","unstructured":"Perl A, Hanczko R, Lai ZW, Oaks Z, Kelly R, Borsuk R, et al. Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin. Metabolomics. 2015;11:1157\u201374.","journal-title":"Metabolomics"},{"key":"2264_CR64","first-page":"2012","volume":"28","author":"SSS Sipka","year":"2001","unstructured":"Sipka SSS, Szucs K, Kov\u00e1cs I, Kiss E, Antal-Szam\u00e1s P, Lakos G, Aleksza M, Ill\u00e9s A, Gergely P, Szegedi G. Decreased arachidonic acid release in peripheral blood monocytes of patients with systemic lupus erythematosus. J Rheumatol. 2001;28:2012\u20137.","journal-title":"J Rheumatol"},{"key":"2264_CR65","doi-asserted-by":"crossref","unstructured":"Coras R, Murillo-Saich JD, Guma M. Circulating pro- and anti-inflammatory metabolites and its potential role in rheumatoid arthritis pathogenesis. Cells. 2020;9.","DOI":"10.3390\/cells9040827"},{"key":"2264_CR66","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13075-018-1655-3","volume":"20","author":"R Narasimhan","year":"2018","unstructured":"Narasimhan R, Coras R, Rosenthal SB, Sweeney SR, Lodi A, Tiziani S, et al. Serum metabolomic profiling predicts synovial gene expression in rheumatoid arthritis. Arthritis Res Ther. 2018;20:164.","journal-title":"Arthritis Res Ther"},{"key":"2264_CR67","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1021\/acs.jproteome.8b00455","volume":"17","author":"JR Anderson","year":"2018","unstructured":"Anderson JR, Chokesuwattanaskul S, Phelan MM, Welting TJM, Lian LY, Peffers MJ, et al. (1) H NMR metabolomics identifies underlying inflammatory pathology in osteoarthritis and rheumatoid arthritis synovial joints. J Proteome Res. 2018;17:3780\u201390.","journal-title":"J Proteome Res"},{"key":"2264_CR68","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/cei.12683","volume":"182","author":"G Kageyama","year":"2015","unstructured":"Kageyama G, Saegusa J, Irino Y, Tanaka S, Tsuda K, Takahashi S, et al. Metabolomics analysis of saliva from patients with primary Sjogren\u2019s syndrome. Clin Exp Immunol. 2015;182:149\u201353.","journal-title":"Clin Exp Immunol"},{"key":"2264_CR69","doi-asserted-by":"crossref","unstructured":"Fernandez-Ochoa A, Brunius C, Borras-Linares I, Quirantes-Pine R, Cadiz-Gurrea ML, Precisesads Clinical C, et al. Metabolic disturbances in urinary and plasma samples from seven different systemic autoimmune diseases detected by HPLC-ESI-QTOF-MS. J Proteome Res 2020.","DOI":"10.1021\/acs.jproteome.0c00179"},{"key":"2264_CR70","first-page":"393","volume":"37","author":"AKRR Carlson","year":"2019","unstructured":"Carlson AKRR, Wallace CW, Adams E, Greenwood MC, Bothner B, June RK. Global metabolomic profiling of human synovial fluid for rheumatoid arthritis biomarkers. Clin Exp Rheumatol. 2019;37:393\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"2264_CR71","doi-asserted-by":"crossref","first-page":"112999","DOI":"10.1016\/j.jpba.2019.112999","volume":"179","author":"A Fernandez-Ochoa","year":"2020","unstructured":"Fernandez-Ochoa A, Borras-Linares I, Quirantes-Pine R, Alarcon-Riquelme ME, Beretta L, Segura-Carretero A, et al. Discovering new metabolite alterations in primary Sjogren\u2019s syndrome in urinary and plasma samples using an HPLC-ESI-QTOF-MS methodology. J Pharm Biomed Anal. 2020;179:112999.","journal-title":"J Pharm Biomed Anal"},{"key":"2264_CR72","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/annrheumdis-2019-216374","volume":"79","author":"M Souto-Carneiro","year":"2020","unstructured":"Souto-Carneiro M, Toth L, Behnisch R, Urbach K, Klika KD, Carvalho RA, et al. Differences in the serum metabolome and lipidome identify potential biomarkers for seronegative rheumatoid arthritis versus psoriatic arthritis. Ann Rheum Dis. 2020;79:499\u2013506.","journal-title":"Ann Rheum Dis"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02264-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-020-02264-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02264-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T00:12:17Z","timestamp":1626480737000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-020-02264-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,17]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2264"],"URL":"https:\/\/doi.org\/10.1186\/s13075-020-02264-2","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,17]]},"assertion":[{"value":"12 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"172"}}